List of Translational Drug Development (Td2) patents

Patent 11420947 was granted and assigned to Translational Drug Development (Td2) on August, 2022 by the United States Patent and Trademark Office.

Patent 11236052 was granted and assigned to Translational Drug Development (Td2) on February, 2022 by the United States Patent and Trademark Office.

Patent 11555039 was granted and assigned to Translational Drug Development (Td2) on January, 2023 by the United States Patent and Trademark Office.

Patent 10392402 was granted and assigned to Translational Drug Development (Td2) on August, 2019 by the United States Patent and Trademark Office.

Patent 10807966 was granted and assigned to Translational Drug Development (Td2) on October, 2020 by the United States Patent and Trademark Office.

Patent 10590088 was granted and assigned to Translational Drug Development (Td2) on March, 2020 by the United States Patent and Trademark Office.

Patent 10131654 was granted and assigned to Translational Drug Development (Td2) on November, 2018 by the United States Patent and Trademark Office.

Patent 10584119 was granted and assigned to Translational Drug Development (Td2) on March, 2020 by the United States Patent and Trademark Office.

Patent 10881733 was granted and assigned to Translational Drug Development (Td2) on January, 2021 by the United States Patent and Trademark Office.

Patent 12076401 was granted and assigned to Translational Drug Development (Td2) on September, 2024 by the United States Patent and Trademark Office.

Patent 11780816 was granted and assigned to Translational Drug Development (Td2) on October, 2023 by the United States Patent and Trademark Office.